COMMUNIQUÉS West-GlobeNewswire
-
InspireMD Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
07/08/2026 -
Intellia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
07/08/2026 -
aTyr Pharma Announces Second Quarter 2026 Results, Program Prioritization and Corporate Restructuring to Support Efzofitimod Program in ILD
07/08/2026 -
Arcutis Biotherapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
07/08/2026 -
PetVivo Sets Fiscal First Quarter 2027 Conference Call for Friday, August 14, 2026 at 5:00 p.m. ET
07/08/2026 -
DirectMax Prescription Management Update Details Patient Support and Telehealth Access Through Direct Meds
07/08/2026 -
Cartesian Therapeutics Announces New Employment Inducement Grants
07/08/2026 -
Minerva Neurosciences Provides Second Quarter 2026 Financial Results and Business Updates
07/08/2026 -
Vireo Growth Receives Regulatory Approval and Completes Acquisition of PharmaCann Colorado Retail Assets
07/08/2026 -
FDA Completes First-Cycle Review of Preservative-Free Ketamine ANDA with No Drug Related Major Deficiencies; Final Packaging Certification Requested for Approval
07/08/2026 -
Rapid Micro Biosystems Reports Second Quarter 2026 Financial Results
07/08/2026 -
ANI Pharmaceuticals Reports Record Second Quarter 2026 Financial Results
07/08/2026 -
UPDATE - CurePSP Announces Enrollment of First Participant in the PSP Trial Platform
07/08/2026 -
Progyny, Inc. to Present at the Canaccord Genuity Annual Growth Conference
07/08/2026 -
Femasys Secures $30 Million Private Placement, with Potential Proceeds of Up to $90 Million
07/08/2026 -
ChemoMetec A/S invites to conference call on September 11, 2026 at 3:00 p.m. CEST on its upcoming 2025/26 Annual Report
07/08/2026 -
CurePSP Announces Enrollment of First Participant in the PSP Trial Platform
07/08/2026 -
Vireo Growth Announces Asset Based Credit Facility
07/08/2026 -
AVITA Medical Announces Participation at Canaccord Genuity Growth Conference
07/08/2026
Pages